April 8, 2015 / 3:08 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Lululemon, Pentair, Mylan, Zep

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes were little changed on Wednesday, with traders eyeing a $70 billion mega-deal in the energy space and ahead of minutes from the most recent meeting of the Federal Reserve's policy-setting committee. The Dow Jones industrial average was up 0.04 percent at 17,882.02, the S&P 500 was up 0.04 percent at 2,077.06 and the Nasdaq Composite was up 0.40 percent at 4,930.101.

** ROYAL DUTCH SHELL PLC, $60.45, -7.65 pct

** BP PLC, $41.13, +2.19 pct

Royal Dutch Shell agreed to buy smaller rival BG Group for 47 billion pounds ($70.2 billion) in the first major energy industry merger in more than a decade, closing the gap on market leader U.S. ExxonMobil after a plunge in prices.

Shares of rival BP rose after the news.

** PENTAIR PLC, $61.29, -4.92 pct

The pump and filter maker estimated first-quarter revenue of $1.48 billion and a profit of 65 cents per share, lower than its forecast. The company said its revenue in the quarter ended March 28 was hurt by a stronger dollar and slower-than-expected oil and gas industry shipments.

** LULULEMON ATHLETICA INC, $68.85, +3.67 pct

Sterne Agee raised its rating on the Canadian yogawear retailer’s stock to “buy” from “hold”. Analysts at Sterne Agee said they expected the company’s 2015 investments to pay off by early next year and new offerings for men and women to attract customers and drive sales and margins by the fourth quarter of 2015 or the first quarter of 2016.

** MYLAN NV, $63.13, +5.98 pct

J.P. Morgan Securities raised its price target on the generic drug maker’s stock to $70 from $66. Merits from a potential merger between Teva Pharmaceutical Industries Ltd and Mylan can be “hard to ignore”, JP Morgan analysts wrote in a note.

** AMERICAN AIRLINES GROUP INC, $48.69, +2.52 pct

American Airlines and US Airways were given a single operating certificate from U.S. regulators, marking a milestone in their integration since the carriers merged in December 2013, parent American Airlines Group said.

** SECOND SIGHT MEDICAL PRODUCTS INC, $14.3608, +13.79 pct

The eye implant maker said new prosthesis for eye to treat “nearly all forms of blindness” was successfully implanted in an animal study.

** MCEWEN MINING INC, $1.02, -3.77 pct

The Canada-based miner said armed robbers stole about 7,000 ounces of gold contained in some 900 kilograms of gold-bearing concentrate from its El Gallo 1 mine in Mexico. The company said its insurance policy was not sufficient to cover the entire amount of expected loss.

** ZEP INC, $20.07, +17.44 pct

The maker of maintenance and cleaning chemicals agreed to be taken private by New Mountain Capital for about $692 million, including debt.

** TESLA MOTORS INC, $206.66, +1.68 pct

The electric sports-car maker said it had started taking orders for new base version of Model S electric sedan. The Model S electric sedan costs $5,000 more than its predecessor, but offers better performance, longer range and more features, including all-wheel drive.


The movie studio announced late on Tuesday a secondary offering of 10 million shares by investment funds affiliated with MHR Fund Management LLC.

** CAPITALA FINANCE CORP, $17.85, -5.51 pct

The business development company announced on Tuesday an offering of 3.5 million shares of common stock.

** REGULUS INC, $18.48, +15.86 pct

The drug developer said AstraZeneca Plc selected its experimental drug, RG-125, for early-stage trial on Non Alcoholic Steatohepatitis (NASH) patients, as part of a strategic alliance signed in 2012.


The vaccine developer said it would receive a grant from the U.S. Department of Defense to lead a team to develop multiple therapies for Ebola, which has killed at least 10,000 people so far. Inovio is the prime contractor on the $45 million program, with other collaborators including MedImmune, a unit of AstraZeneca Plc and GeneOne Life Sciences.

** EVERYWARE GLOBAL INC, $0.215, +7.50 pct

The marketer of cookware and tabletop products filed for Chapter 11 bankruptcy protection late on Tuesday. The company listed assets of $100 million-$500 million and liabilities of $500 million-$1 billion in its petition in the Delaware bankruptcy court. (Compiled by Neha Dimri in Bengaluru; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below